发明名称 Hemoglobin mutants with increased soluble expression and/or reduced nitric oxide scavenging
摘要 A method of expressing a hemoglobin, comprising: (a) providing a host cell containing nucleotide sequences encoding globins capable of associating to form a functional hemoglobin, wherein a nucleotide sequence encodes a ² globin having at least one mutation or combination of mutations selected from the group consisting of D73I, D73M, D73E, D73T, D73K, D73L, K82E, K82G, K82P, K82Q, K82S, K82N, K82H, N102A, N102V, K82D (Providence) + D73G (Tilberg), and K82D (Providence) + D73Y (Vancouver); (b) inducing the host cell to express the hemoglobin; and (c) purifying the hemoglobin from the host cell.
申请公布号 EP1950298(A2) 申请公布日期 2008.07.30
申请号 EP20080075054 申请日期 1998.05.01
申请人 BAXTER BIOTECH TECHNOLOGY S.A.R.L.;WILLIAM MARSH RICE UNIVERSITY 发明人 WEICKERT, MICHAEL J.;GLASCOCK, CHRISTOPHER B.;MATHEWS, ANTONY J.;LEMON, DOUGLAS D.;DOHERTY, DANIEL H.;OLSON, JOHN S.
分类号 C12N15/09;C12N15/12;A61K38/00;C07K14/805;C12N1/21;C12P21/02 主分类号 C12N15/09
代理机构 代理人
主权项
地址